bluebird bio, Inc.
BLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $84 | $29 | $4 | $4 |
| % Growth | 184.1% | 720% | -1.8% | – |
| Cost of Goods Sold | $89 | $34 | $10 | $39 |
| Gross Profit | -$6 | -$4 | -$6 | -$35 |
| % Margin | -6.6% | -13.7% | -180.2% | -961.1% |
| R&D Expenses | $94 | $168 | $241 | $320 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $168 | $166 | $137 | $210 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | -$93 | -$134 | $26 |
| Operating Expenses | $265 | $240 | $244 | $556 |
| Operating Income | -$270 | -$244 | -$250 | -$591 |
| % Margin | -322.7% | -828.1% | -6,955.4% | -16,136.3% |
| Other Income/Exp. Net | $30 | $32 | $20 | $29 |
| Pre-Tax Income | -$241 | -$212 | -$230 | -$562 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$241 | -$212 | -$230 | -$819 |
| % Margin | -287.2% | -718.4% | -6,403.7% | -22,375.2% |
| EPS | -24.84 | -2.97 | -3.39 | -8.16 |
| % Growth | -736.4% | 12.4% | 58.5% | – |
| EPS Diluted | -24.84 | -2.97 | -3.39 | -8.16 |
| Weighted Avg Shares Out | 10 | 71 | 79 | 69 |
| Weighted Avg Shares Out Dil | 10 | 71 | 79 | 69 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $10 | $1 | $1 |
| Interest Expense | $23 | $16 | $6 | $0 |
| Depreciation & Amortization | $61 | $29 | $8 | $5 |
| EBITDA | -$157 | -$167 | -$216 | -$557 |
| % Margin | -187.1% | -566.7% | -5,992.7% | -15,208.2% |